
Financial Data and Key Metrics Changes - For the cumulative results from Q1 to Q3, there was a decrease in both revenue and operating profit compared to the previous year, attributed to a decline in semiconductor-related sales and one-time costs of approximately ¥5 billion due to headquarters relocation [2][5][28] - The third quarter alone also showed a decrease in revenue and operating profit, with one-time costs of approximately ¥2.1 billion including restructuring costs and impairment losses [3][5][28] Business Line Data and Key Metrics Changes - Imaging Products Business: Revenue increased by ¥13.7 million year-on-year to ¥235.6 billion, and operating profit increased by ¥900 million to ¥43.8 billion, driven by new product launches [7][36] - Precision Equipment Business: Revenue decreased by ¥29.6 billion year-on-year to ¥124.9 billion, with operating profit down by ¥11.7 billion to a loss of ¥600 million, primarily due to a decline in semiconductor sales [10][37] - Healthcare Business: Overall revenue increased by ¥4.7 billion year-on-year to ¥81.5 billion, but operating profit decreased by ¥800 million to ¥2.1 billion due to market stagnation in Life Science Solutions [12][39] - Components Business: Revenue decreased by ¥10.3 billion to ¥49 billion, and operating profit decreased by ¥7.1 billion to ¥3.6 billion due to a decline in EUV-related component sales [13][40] - Digital Manufacturing Business: Revenue increased by ¥4.3 billion year-on-year to ¥18.2 billion, but operating profit saw a deficit of ¥1.7 billion [14][41] Market Data and Key Metrics Changes - The Imaging Products Business continues to be a major pillar of earnings, focusing on mid to high-end models for professionals and hobbyists [9][36] - The Healthcare Business is experiencing signs of recovery in Europe and the United States, despite concerns about high interest rates in the U.S. and economic downturn in China [50][49] Company Strategy and Development Direction - The company aims to significantly increase its share in the ArF immersion lithography systems market, expected to expand as 3D technology is adopted in DRAM and logic segments [21][29] - The Imaging Products Business will focus on expanding sales of mirrorless cameras and launching new products in the next fiscal year [30][57] Management's Comments on Operating Environment and Future Outlook - The management noted that the semiconductor-related business is expected to recover in the second half of the next fiscal year, although the order environment remains unclear [56][29] - Concerns about excess inventory in the camera market, particularly in China, were highlighted, but the overall camera market continues to expand [46][45] Other Important Information - The full-year operating profit forecast has been revised down by ¥3 billion to ¥19 billion due to a decline in sales in the Components Business [28][55] - The company plans to maintain the annual dividend at ¥55 and has initiated a share buyback program [42][43] Q&A Session Summary Question: What are the expectations for the semiconductor-related business recovery? - Management expects the semiconductor-related business in the Precision Equipment and Components Business to recover in the second half of the next fiscal year, but the order environment is still unclear [56][29] Question: How is the company addressing the concerns about excess inventory in the camera market? - The company is maintaining its sales volume forecasts for interchangeable lens cameras and lenses, while acknowledging concerns about excess inventory, particularly in China [46][45]